| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |